--- title: "Stocks in Play: Oncolytics Biotech Inc" type: "News" locale: "en" url: "https://longbridge.com/en/news/296240374.md" description: "09:57 AM EST - Oncolytics Biotech Inc : Announces it has received written feedback from the U.S. Food and Drug Administration regarding the design of a potential pivotal Part B expansion of REO 033, the Company’s ongoing randomized study evaluating pelareorep in second-line RAS-mutant, microsatellite stable metastatic colorectal cancer. Oncolytics Biotech Inc sharesNCY are trading up one cent at $0.83.Full Press Release:" datetime: "2026-08-18T14:01:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296240374.md) - [en](https://longbridge.com/en/news/296240374.md) - [zh-HK](https://longbridge.com/zh-HK/news/296240374.md) generator: "portal-rs" --- # Stocks in Play: Oncolytics Biotech Inc **09:57 AM EST - Oncolytics Biotech Inc :** Announces it has received written feedback from the U.S. Food and Drug Administration regarding the design of a potential pivotal Part B expansion of REO 033, the Company’s ongoing randomized study evaluating pelareorep in second-line RAS-mutant, microsatellite stable metastatic colorectal cancer. Oncolytics Biotech Inc shares N.ONCY are trading **up one cent** at $0.83. *Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=4568478878479694* ### Related Stocks - [ONCY.US](https://longbridge.com/en/quote/ONCY.US.md) ## Related News & Research - [Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $5.00 by Analysts at HC Wainwright](https://longbridge.com/en/news/296357626.md) - [Why Now Could Be the Right Time to Buy Super Micro Computer Stock](https://longbridge.com/en/news/297543492.md) - [Ambiq Micro CEO Makes Major Move With Multimillion-Dollar Stock Sale](https://longbridge.com/en/news/297855871.md) - [Ambiq Micro CEO Fumihide Esaka disposes of 108,500 common shares worth $6.19 million](https://longbridge.com/en/news/297829413.md) - [Stolper Co Sells 12,780 Shares of Microsoft Corporation $MSFT](https://longbridge.com/en/news/298010029.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**